IDEAYA Biosciences (IDYA) Competitors $20.47 +0.34 (+1.69%) Closing price 05/1/2025 04:00 PM EasternExtended Trading$21.33 +0.86 (+4.20%) As of 04:17 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IDYA vs. LEGN, TGTX, TLX, BPMC, SRPT, AXSM, NUVL, VRNA, GRFS, and KRYSShould you be buying IDEAYA Biosciences stock or one of its competitors? The main competitors of IDEAYA Biosciences include Legend Biotech (LEGN), TG Therapeutics (TGTX), Telix Pharmaceuticals Limited American Depositary Shares (TLX), Blueprint Medicines (BPMC), Sarepta Therapeutics (SRPT), Axsome Therapeutics (AXSM), Nuvalent (NUVL), Verona Pharma (VRNA), Grifols (GRFS), and Krystal Biotech (KRYS). These companies are all part of the "pharmaceutical products" industry. IDEAYA Biosciences vs. Legend Biotech TG Therapeutics Telix Pharmaceuticals Limited American Depositary Shares Blueprint Medicines Sarepta Therapeutics Axsome Therapeutics Nuvalent Verona Pharma Grifols Krystal Biotech IDEAYA Biosciences (NASDAQ:IDYA) and Legend Biotech (NASDAQ:LEGN) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations, community ranking, media sentiment and institutional ownership. Does the media prefer IDYA or LEGN? In the previous week, IDEAYA Biosciences had 5 more articles in the media than Legend Biotech. MarketBeat recorded 12 mentions for IDEAYA Biosciences and 7 mentions for Legend Biotech. Legend Biotech's average media sentiment score of 1.25 beat IDEAYA Biosciences' score of 1.15 indicating that Legend Biotech is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IDEAYA Biosciences 6 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Legend Biotech 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is IDYA or LEGN more profitable? IDEAYA Biosciences has a net margin of 0.00% compared to Legend Biotech's net margin of -66.92%. IDEAYA Biosciences' return on equity of -26.74% beat Legend Biotech's return on equity.Company Net Margins Return on Equity Return on Assets IDEAYA BiosciencesN/A -26.74% -25.54% Legend Biotech -66.92%-29.69%-19.45% Does the MarketBeat Community prefer IDYA or LEGN? IDEAYA Biosciences received 52 more outperform votes than Legend Biotech when rated by MarketBeat users. However, 72.58% of users gave Legend Biotech an outperform vote while only 71.72% of users gave IDEAYA Biosciences an outperform vote. CompanyUnderperformOutperformIDEAYA BiosciencesOutperform Votes14271.72% Underperform Votes5628.28% Legend BiotechOutperform Votes9072.58% Underperform Votes3427.42% Which has more volatility and risk, IDYA or LEGN? IDEAYA Biosciences has a beta of 0.51, meaning that its share price is 49% less volatile than the S&P 500. Comparatively, Legend Biotech has a beta of 0.21, meaning that its share price is 79% less volatile than the S&P 500. Do analysts rate IDYA or LEGN? IDEAYA Biosciences presently has a consensus target price of $53.58, suggesting a potential upside of 161.77%. Legend Biotech has a consensus target price of $78.82, suggesting a potential upside of 132.09%. Given IDEAYA Biosciences' stronger consensus rating and higher possible upside, equities research analysts plainly believe IDEAYA Biosciences is more favorable than Legend Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IDEAYA Biosciences 0 Sell rating(s) 2 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 2.93Legend Biotech 0 Sell rating(s) 1 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.92 Do insiders and institutionals hold more shares of IDYA or LEGN? 98.3% of IDEAYA Biosciences shares are owned by institutional investors. Comparatively, 70.9% of Legend Biotech shares are owned by institutional investors. 3.5% of IDEAYA Biosciences shares are owned by company insiders. Comparatively, 0.0% of Legend Biotech shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has stronger valuation & earnings, IDYA or LEGN? IDEAYA Biosciences has higher earnings, but lower revenue than Legend Biotech. Legend Biotech is trading at a lower price-to-earnings ratio than IDEAYA Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIDEAYA Biosciences$7M255.98-$274.48M-$3.30-6.20Legend Biotech$627.24M9.94-$518.25M-$0.48-70.75 SummaryIDEAYA Biosciences beats Legend Biotech on 14 of the 19 factors compared between the two stocks. Get IDEAYA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IDYA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IDYA vs. The Competition Export to ExcelMetricIDEAYA BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.79B$6.84B$5.53B$7.93BDividend YieldN/A3.05%5.11%4.22%P/E Ratio-6.207.3222.5918.54Price / Sales255.98241.43401.35103.29Price / CashN/A65.8538.1834.62Price / Book1.696.486.774.25Net Income-$274.48M$143.41M$3.22B$248.18M7 Day Performance7.74%2.58%1.39%1.03%1 Month Performance25.20%5.00%2.78%2.70%1 Year Performance-50.66%-3.72%15.85%4.05% IDEAYA Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IDYAIDEAYA Biosciences3.7082 of 5 stars$20.47+1.7%$53.58+161.8%-50.3%$1.79B$7M-6.2080Upcoming EarningsPositive NewsLEGNLegend Biotech2.6365 of 5 stars$32.24-1.7%$79.00+145.0%-22.8%$5.92B$627.24M-33.941,070Positive NewsTGTXTG Therapeutics3.3045 of 5 stars$36.97-3.5%$40.67+10.0%+185.7%$5.81B$329.00M-369.66290Upcoming EarningsPositive NewsTLXTelix Pharmaceuticals Limited American Depositary SharesN/A$16.21-3.0%$22.00+35.7%N/A$5.48B$783.21M0.00N/AAnalyst RevisionNews CoverageGap DownBPMCBlueprint Medicines2.5578 of 5 stars$84.18-0.6%$124.95+48.4%+4.6%$5.38B$508.82M-77.94640Earnings ReportAnalyst ForecastPositive NewsSRPTSarepta Therapeutics4.7419 of 5 stars$55.23+2.7%$158.70+187.3%-52.0%$5.36B$1.90B44.18840Upcoming EarningsAXSMAxsome Therapeutics4.832 of 5 stars$103.00-1.4%$169.80+64.9%+49.9%$5.02B$385.69M-17.20380Upcoming EarningsAnalyst ForecastShort Interest ↓Positive NewsNUVLNuvalent1.8833 of 5 stars$69.95-2.4%$115.50+65.1%+7.9%$5.01BN/A-20.1640Upcoming EarningsPositive NewsVRNAVerona Pharma2.9044 of 5 stars$60.07+2.0%$75.43+25.6%+374.8%$4.85B$42.28M-31.2930Earnings ReportAnalyst ForecastInsider TradeShort Interest ↓Analyst RevisionNews CoveragePositive NewsGRFSGrifols3.8942 of 5 stars$7.01-1.0%N/A+3.4%$4.82B$7.21B5.9926,300Short Interest ↓Positive NewsKRYSKrystal Biotech4.905 of 5 stars$161.91-4.0%$220.00+35.9%+3.8%$4.68B$290.52M54.15210Upcoming EarningsAnalyst RevisionPositive News Related Companies and Tools Related Companies Legend Biotech Alternatives TG Therapeutics Alternatives Telix Pharmaceuticals Limited American Depositary Shares Alternatives Blueprint Medicines Alternatives Sarepta Therapeutics Alternatives Axsome Therapeutics Alternatives Nuvalent Alternatives Verona Pharma Alternatives Grifols Alternatives Krystal Biotech Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IDYA) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IDEAYA Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IDEAYA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IDYA Stock Free IDYA Stock Alerts